ImmuCell Corporation (NASDAQ:ICCC) Q3 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the ImmuCell Corporation Reports Third Quarter ended September 30, 2025, Unaudited Financial Results Conference Call.
Immucell Corp (ICCC)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 157,289 | $983,056 | -2% | 0% |
| 2. | Citadel Investment Group Ken Griffin | 21,469 | $138,904 | -48% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.50 | 2,432 | $13,376.49 | 9,738 | 2025-12-04 | Filing | |
| $5.05 | 3,598 | $18,151.91 | 7,306 | 2025-12-03 | Filing | |
| $5.04 | 3,521 | $17,747.95 | 9,785 | 2025-12-03 | Filing | |
| $5.00 | 2,556 | $12,787.67 | 6,264 | 2025-12-03 | Filing | |
| $4.87 | 3,708 | $18,052.77 | 3,708 | 2025-12-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.60 | 200 | $1,320.00 | 105,111 | 2016-07-08 | Filing | |
| $6.59 | 394 | $2,596.46 | 105,311 | 2016-07-08 | Filing | |
| $6.55 | 500 | $3,275.00 | 105,705 | 2016-07-08 | Filing | |
| $6.51 | 100 | $651.00 | 106,205 | 2016-07-08 | Filing | |
| $6.50 | 400 | $2,600.00 | 106,305 | 2016-07-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 308,702 | $1,997,302 | 0% | |
| 2. | 132,001 | $854,046 | 0% | |
| 3. | 105,116 | $656,975 | 0% | |
| 4. | 101,594 | $634,963 | 0.12% | |
| 5. | 87,121 | $544,506 | 0.34% |
News See All
ImmuCell Corporation (NASDAQ:ICCC) Q2 2025 Earnings Call Transcript
Operator: Good morning, and welcome to ImmuCell Corporation Reports Second Quarter Ended June 30, 2025 Unaudited Financial Results Conference Call.
ImmuCell Corporation (NASDAQ:ICCC) Q1 2025 Earnings Call Transcript
Operator: Good morning and welcome to the ImmuCell Corporation Reports First Quarter Ended March 31st, 2025 Audited Financial Results Conference Call. All participants will be in listen-only mode.
ImmuCell Corporation (NASDAQ:ICCC) Q4 2024 Earnings Call Transcript
Operator: Good morning, and welcome to ImmuCell Corporation Reports its Fourth Quarter and Year Ended December 31, 2024, Unaudited Financial Results Conference Call.
ImmuCell Corporation (NASDAQ:ICCC) Q3 2024 Earnings Call Transcript
Operator: Good morning and welcome to ImmuCell Corporation Reports Third Quarter September 30, 2024, Unaudited Financial Results Conference Call. All participants will be in listen-only mode.
ImmuCell Corporation (NASDAQ:ICCC) Q2 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the ImmuCell Corporation Reports Second Quarter ended June 30, 2024, Unaudited Financial Results Conference Call. All participants will be in a listen-only mode.
ImmuCell Corporation (NASDAQ:ICCC) Q1 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the ImmuCell Corporation Reports First Quarter ended March 31, 2024 Unaudited Financial Results Conference Call. All participants are in a listen-only mode.
ImmuCell Corporation (NASDAQ:ICCC) Q4 2023 Earnings Call Transcript
Operator: Good morning and welcome to the ImmuCell Corporation reports Fourth Quarter and Year Ended December 31, 2023 Unaudited Financial Results Conference Call.
ImmuCell Corporation (NASDAQ:ICCC) Q3 2023 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the ImmuCell Corporation's Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.
Top 20 Animal Health Companies in the World
In this article, we will take a detailed look at the Top 20 Animal Health Companies in the World with insights into the revenue generated in 2022.
Hedge Fund Resource Center Billionaire Hedge Funds
